Handelsavisen
prelaunch
Companies Healthcare AHCO.O
AH
AHCO.O NASDAQ Health Care Providers & Services

Ahco.O

$10,24
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
1,4B USD
P/E
EV / Rev
Div yield
Op margin
2,8 %
ROE
-4,7 %
Net margin
-2,2 %
Debt / equity
1,13
Beta
52w range
Volume
Day range
Prev close
$10,68
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

AHCO.O operates as a health care provider and services entity, generating revenue through its disclosed business activities within the health care sector.

Business. AHCO.O operates as a health care provider and services entity, generating revenue through its disclosed business activities within the health care sector.

Classification85 %
SectorHealth Care
Industry groupHealth Care Providers & Services
Generated · model-assisted
Sell-side consensus
BUY8 analysts
6 buy2 hold0 sell
Avg 12m price target13,19

Analyst recommendations

8 analysts · consensus Buy
Buy6
Hold2
Sell0
12-month price target
13,19
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
8 analysts · indicative
Ownership
Principal Global Investors (Equity)
largest disclosed fund holder
Profitability
-4,7 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning AHCO.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,7 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,4 %−2,7 %−0,9 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Consumer Staples−0,7 %+2,3 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to AHCO.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR
    • Congressional trades
    • CongressKevin Hern — AdaptHealth Corp.2023-04-06 · Republican · OK · Sale · $1,001 - $15,000
    • CongressSusie Lee — AdaptHealth Corp.2022-11-30 · Democrat · NV · Sale · $1,001 - $15,000
    • CongressKevin Hern — AdaptHealth Corp.2022-04-22 · Republican · OK · Sale · $1,001 - $15,000
    • CongressKevin Hern — AdaptHealth Corp.2022-04-01 · Republican · OK · Sale · $50,001 - $100,000
    • CongressKevin Hern — AdaptHealth Corp.2021-08-25 · Republican · OK · Purchase · $100,001 - $250,000

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    AHCO.O operates as a health care provider and services entity, generating revenue through its disclosed business activities within the health care sector.

    Classification85 %
    SectorHealth Care
    Industry groupHealth Care Providers & Services
    AI synthesis
    GENERATED

    AHCO.O maintains a capital structure characterized by significant leverage, with long-term debt of $1.72 billion against total equity of $1.52 billion, resulting in a debt-to-equity ratio of 1.13. The company reports a market capitalization of $1.46 billion and trades at a price-to-book ratio of 0.96, indicating valuation near tangible book value. Liquidity is assessed as medium risk, with a key flag noting that net cash is negative after subtracting total debt, despite operating cash flow of $602 million.

    Profitability metrics reflect current operational challenges, with a net income loss of $70.8 million and an operating income of $90.9 million on revenue of $3.24 billion. Return on equity stands at -4.66% and return on assets at -1.64%, signaling inefficient capital deployment relative to the asset base of $4.32 billion. The enterprise value to EBITDA multiple is 34.98, suggesting high valuation relative to earnings power, while EV to revenue is 0.98.

    Segment and geographic revenue concentration data is not available in the provided input, preventing detailed analysis of revenue mix or regional exposure. The company’s total assets of $4.32 billion and liabilities of $2.79 billion indicate a substantial balance sheet presence, but without segment breakdowns, the specific drivers of the $3.24 billion revenue stream remain opaque.

    Historical growth trajectory data is absent from the input, limiting the ability to assess revenue trends or net income progression over time. The current financial snapshot shows capital expenditures of $382 million, which is substantial relative to operating cash flow, potentially impacting free cash flow generation.

    Risk assessment highlights medium liquidity risk and low dilution risk, with the primary concern being the negative net cash position after debt subtraction. The company has 135.45 million shares outstanding, with no difference between basic and diluted shares, indicating no immediate dilutive securities in the current period.

    Recent observations include analyst estimates with a mean price target of $13.19 and a median of $13.50, reflecting a positive sentiment relative to the current market price of $10.80. The mean recommendation is 2.00, with two strong buys, four buys, and two holds, suggesting institutional confidence in future performance. News events indicate system reconciler activities but no specific corporate actions or disclosures.

    Key takeaways
    • AHCO.O trades at a price-to-book ratio of 0.96, near tangible book value, with a market cap of $1.46 billion.
    • The company reports a net loss of $70.8 million and negative returns on equity (-4.66%) and assets (-1.64%).
    • High leverage is evident with a debt-to-equity ratio of 1.13 and long-term debt of $1.72 billion.
    • Analyst sentiment is positive, with a mean price target of $13.19 and a mean recommendation of 2.00.
    • Liquidity risk is medium due to negative net cash after debt, despite $602 million in operating cash flow.
    • Dilution risk is low, with no difference between basic and diluted shares outstanding.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $10,24
    Market cap
    $1.46B
    Enterprise value
    $3.18B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    5.3x
    P / B
    1.0x
    P / Tangible book
    1.0x
    Tangible book
    $1.53B
    Net cash
    -$1.72B
    Current ratio
    Debt / equity
    1.1
    ROA
    -1.6%
    ROE
    -4.7%
    Cash conversion
    -850.0%
    CapEx / revenue
    11.8%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    Business relationships200 disclosed relationships · 1 type · extracted from filings & disclosures
    Subsidiaries200
    EX21:01332cbabee3EX21:01332cbabee3Subsidiarie97%
    EX21:01b21558a7ddEX21:01b21558a7ddSubsidiarie97%
    EX21:02181bda7c50EX21:02181bda7c50Subsidiarie97%
    EX21:070aae01aa0cEX21:070aae01aa0cSubsidiarie97%
    EX21:0770d0026650EX21:0770d0026650Subsidiarie97%
    EX21:0b1c126a6d6dEX21:0b1c126a6d6dSubsidiarie97%
    EX21:0b81dfa6e52bEX21:0b81dfa6e52bSubsidiarie97%
    EX21:0c94028f2642EX21:0c94028f2642Subsidiarie97%
    EX21:0f9c3be4f9abEX21:0f9c3be4f9abSubsidiarie97%
    EX21:1082de06eca6EX21:1082de06eca6Subsidiarie97%
    EX21:1097a1b1d959EX21:1097a1b1d959Subsidiarie97%
    EX21:10df42624ab2EX21:10df42624ab2Subsidiarie97%
    EX21:127e5b540930EX21:127e5b540930Subsidiarie97%
    EX21:157ee0190c46EX21:157ee0190c46Subsidiarie97%
    EX21:1647be26cb67EX21:1647be26cb67Subsidiarie97%
    EX21:16ab64c0ff2bEX21:16ab64c0ff2bSubsidiarie97%
    EX21:17956cb54362EX21:17956cb54362Subsidiarie97%
    EX21:18689569a26dEX21:18689569a26dSubsidiarie97%
    EX21:18926aeda8a0EX21:18926aeda8a0Subsidiarie97%
    EX21:1980b9a9377cEX21:1980b9a9377cSubsidiarie97%
    EX21:1b075cc86895EX21:1b075cc86895Subsidiarie97%
    EX21:1b64359d1db1EX21:1b64359d1db1Subsidiarie97%
    EX21:1bd87eb2f509EX21:1bd87eb2f509Subsidiarie97%
    EX21:1cc7358475e9EX21:1cc7358475e9Subsidiarie97%
    EX21:1da827232cedEX21:1da827232cedSubsidiarie97%
    EX21:1f8941a64ff9EX21:1f8941a64ff9Subsidiarie97%
    EX21:20b04a4f018bEX21:20b04a4f018bSubsidiarie97%
    EX21:220ac33e8e4fEX21:220ac33e8e4fSubsidiarie97%
    EX21:260fa07cd66aEX21:260fa07cd66aSubsidiarie97%
    EX21:28b6ea8436e0EX21:28b6ea8436e0Subsidiarie97%
    EX21:2961ca332b73EX21:2961ca332b73Subsidiarie97%
    EX21:2adcb5242deaEX21:2adcb5242deaSubsidiarie97%
    EX21:2af1c87d11feEX21:2af1c87d11feSubsidiarie97%
    EX21:2b048ff048c8EX21:2b048ff048c8Subsidiarie97%
    EX21:2bfe6c31940dEX21:2bfe6c31940dSubsidiarie97%
    EX21:2e0c8ec204a4EX21:2e0c8ec204a4Subsidiarie97%
    EX21:2e7530f08152EX21:2e7530f08152Subsidiarie97%
    EX21:2f9e4fa97b6fEX21:2f9e4fa97b6fSubsidiarie97%
    EX21:2fb9f65bfb8eEX21:2fb9f65bfb8eSubsidiarie97%
    EX21:32b751f136e9EX21:32b751f136e9Subsidiarie97%
    EX21:357b7bdeefbaEX21:357b7bdeefbaSubsidiarie97%
    EX21:35f60c7a02d2EX21:35f60c7a02d2Subsidiarie97%
    EX21:36297e183da1EX21:36297e183da1Subsidiarie97%
    EX21:39a0b457fc13EX21:39a0b457fc13Subsidiarie97%
    EX21:3a1a5346f618EX21:3a1a5346f618Subsidiarie97%
    EX21:3a352f75ab9aEX21:3a352f75ab9aSubsidiarie97%
    EX21:3ae3ce2a186fEX21:3ae3ce2a186fSubsidiarie97%
    EX21:3d4ed86388f2EX21:3d4ed86388f2Subsidiarie97%
    EX21:3ebdda56ee8bEX21:3ebdda56ee8bSubsidiarie97%
    EX21:3f2cb6d9fe06EX21:3f2cb6d9fe06Subsidiarie97%
    EX21:4003a1052ac5EX21:4003a1052ac5Subsidiarie97%
    EX21:40737c4d07b1EX21:40737c4d07b1Subsidiarie97%
    EX21:40c3a063f892EX21:40c3a063f892Subsidiarie97%
    EX21:42d0c0a3f376EX21:42d0c0a3f376Subsidiarie97%
    EX21:4539234b362bEX21:4539234b362bSubsidiarie97%
    EX21:473588a18eddEX21:473588a18eddSubsidiarie97%
    EX21:47ace05380b2EX21:47ace05380b2Subsidiarie97%
    EX21:4817a3a449b5EX21:4817a3a449b5Subsidiarie97%
    EX21:4908423e3f87EX21:4908423e3f87Subsidiarie97%
    EX21:4c4cdff6dfd8EX21:4c4cdff6dfd8Subsidiarie97%
    EX21:4c9da6586a90EX21:4c9da6586a90Subsidiarie97%
    EX21:4d69af681eb1EX21:4d69af681eb1Subsidiarie97%
    EX21:4d6d3e9f1ab3EX21:4d6d3e9f1ab3Subsidiarie97%
    EX21:4dd32b6f8c30EX21:4dd32b6f8c30Subsidiarie97%
    EX21:4f57166c9e4cEX21:4f57166c9e4cSubsidiarie97%
    EX21:53c22571385bEX21:53c22571385bSubsidiarie97%
    EX21:53cd841d7a4cEX21:53cd841d7a4cSubsidiarie97%
    EX21:53ec388531e0EX21:53ec388531e0Subsidiarie97%
    EX21:540a2f065c0bEX21:540a2f065c0bSubsidiarie97%
    EX21:55116909831bEX21:55116909831bSubsidiarie97%
    EX21:5616ccd570beEX21:5616ccd570beSubsidiarie97%
    EX21:599e48b976a3EX21:599e48b976a3Subsidiarie97%
    EX21:5b2aecd5d16fEX21:5b2aecd5d16fSubsidiarie97%
    EX21:5b857e952a84EX21:5b857e952a84Subsidiarie97%
    EX21:5bdd3fb34329EX21:5bdd3fb34329Subsidiarie97%
    EX21:5c6997899c02EX21:5c6997899c02Subsidiarie97%
    EX21:6088a856fdeeEX21:6088a856fdeeSubsidiarie97%
    EX21:615139330600EX21:615139330600Subsidiarie97%
    EX21:625e3c7e6f91EX21:625e3c7e6f91Subsidiarie97%
    EX21:633df95ad1a6EX21:633df95ad1a6Subsidiarie97%
    EX21:659476086c78EX21:659476086c78Subsidiarie97%
    EX21:664c6c186a53EX21:664c6c186a53Subsidiarie97%
    EX21:68b6270b7b68EX21:68b6270b7b68Subsidiarie97%
    EX21:68e3866cd5c7EX21:68e3866cd5c7Subsidiarie97%
    EX21:692fe5b62027EX21:692fe5b62027Subsidiarie97%
    EX21:6a5bfc98f9efEX21:6a5bfc98f9efSubsidiarie97%
    EX21:6aaebc20d19dEX21:6aaebc20d19dSubsidiarie97%
    EX21:6abbde69148aEX21:6abbde69148aSubsidiarie97%
    EX21:6b47396cf983EX21:6b47396cf983Subsidiarie97%
    EX21:6d0264785eb7EX21:6d0264785eb7Subsidiarie97%
    EX21:6d485df9b8e4EX21:6d485df9b8e4Subsidiarie97%
    EX21:6d6978beee1dEX21:6d6978beee1dSubsidiarie97%
    EX21:6ddf045f0fd6EX21:6ddf045f0fd6Subsidiarie97%
    EX21:6dfb39a079bdEX21:6dfb39a079bdSubsidiarie97%
    EX21:6e5fec845243EX21:6e5fec845243Subsidiarie97%
    EX21:6edd48092615EX21:6edd48092615Subsidiarie97%
    EX21:6f304971a651EX21:6f304971a651Subsidiarie97%
    EX21:6ffebc1f6a70EX21:6ffebc1f6a70Subsidiarie97%
    EX21:7086c07a1d80EX21:7086c07a1d80Subsidiarie97%
    EX21:7171d4730621EX21:7171d4730621Subsidiarie97%
    EX21:744b3d6fb407EX21:744b3d6fb407Subsidiarie97%
    EX21:74c2a1ddb673EX21:74c2a1ddb673Subsidiarie97%
    EX21:753fb088448fEX21:753fb088448fSubsidiarie97%
    EX21:7f1b3ea3b279EX21:7f1b3ea3b279Subsidiarie97%
    EX21:7f26e71f442aEX21:7f26e71f442aSubsidiarie97%
    EX21:7fda706c936dEX21:7fda706c936dSubsidiarie97%
    EX21:820abb565812EX21:820abb565812Subsidiarie97%
    EX21:837fb707d597EX21:837fb707d597Subsidiarie97%
    EX21:8535196dd636EX21:8535196dd636Subsidiarie97%
    EX21:86114f6cfff7EX21:86114f6cfff7Subsidiarie97%
    EX21:86cf6e3ba114EX21:86cf6e3ba114Subsidiarie97%
    EX21:87621267e168EX21:87621267e168Subsidiarie97%
    EX21:878b704ceab5EX21:878b704ceab5Subsidiarie97%
    EX21:8afc3ea4f7c8EX21:8afc3ea4f7c8Subsidiarie97%
    EX21:8b317a5fda1aEX21:8b317a5fda1aSubsidiarie97%
    EX21:8d13389b4e8fEX21:8d13389b4e8fSubsidiarie97%
    EX21:8e6088c6a79bEX21:8e6088c6a79bSubsidiarie97%
    EX21:9057270e45a2EX21:9057270e45a2Subsidiarie97%
    EX21:90b85891ef2eEX21:90b85891ef2eSubsidiarie97%
    EX21:97ca7cb01f13EX21:97ca7cb01f13Subsidiarie97%
    EX21:982d5cf4e2cdEX21:982d5cf4e2cdSubsidiarie97%
    EX21:985614328e83EX21:985614328e83Subsidiarie97%
    EX21:99de8f587777EX21:99de8f587777Subsidiarie97%
    EX21:9a80628ab4c9EX21:9a80628ab4c9Subsidiarie97%
    EX21:9be6a561484aEX21:9be6a561484aSubsidiarie97%
    EX21:9d483e2f5b47EX21:9d483e2f5b47Subsidiarie97%
    EX21:9e84cf049312EX21:9e84cf049312Subsidiarie97%
    EX21:9eba356a7b71EX21:9eba356a7b71Subsidiarie97%
    EX21:9fba1ca27e59EX21:9fba1ca27e59Subsidiarie97%
    EX21:a1b09e6ec1f4EX21:a1b09e6ec1f4Subsidiarie97%
    EX21:a2a952ce7ec2EX21:a2a952ce7ec2Subsidiarie97%
    EX21:a36ba2e7d253EX21:a36ba2e7d253Subsidiarie97%
    EX21:a4b5c45e3247EX21:a4b5c45e3247Subsidiarie97%
    EX21:ab1fe0b01242EX21:ab1fe0b01242Subsidiarie97%
    EX21:ab5e1cb155b4EX21:ab5e1cb155b4Subsidiarie97%
    EX21:ae0bec9e9d33EX21:ae0bec9e9d33Subsidiarie97%
    EX21:aeeda61ecf97EX21:aeeda61ecf97Subsidiarie97%
    EX21:af31f5153f47EX21:af31f5153f47Subsidiarie97%
    EX21:b1db34d2944dEX21:b1db34d2944dSubsidiarie97%
    EX21:b283e14c28a7EX21:b283e14c28a7Subsidiarie97%
    EX21:b290ed7f9c46EX21:b290ed7f9c46Subsidiarie97%
    EX21:b37869143b12EX21:b37869143b12Subsidiarie97%
    EX21:b50fb215ed38EX21:b50fb215ed38Subsidiarie97%
    EX21:b5b347002e8aEX21:b5b347002e8aSubsidiarie97%
    EX21:b5f82a3d444cEX21:b5f82a3d444cSubsidiarie97%
    EX21:b6bbbe032cd6EX21:b6bbbe032cd6Subsidiarie97%
    EX21:b8f831fdfd01EX21:b8f831fdfd01Subsidiarie97%
    EX21:b96531d529f0EX21:b96531d529f0Subsidiarie97%
    EX21:bc377ea0a695EX21:bc377ea0a695Subsidiarie97%
    EX21:c13c465a4315EX21:c13c465a4315Subsidiarie97%
    EX21:c32fdbd5b5f5EX21:c32fdbd5b5f5Subsidiarie97%
    EX21:c3e0bf555637EX21:c3e0bf555637Subsidiarie97%
    EX21:c4416016c7c4EX21:c4416016c7c4Subsidiarie97%
    EX21:c56e9b132339EX21:c56e9b132339Subsidiarie97%
    EX21:c7de08212916EX21:c7de08212916Subsidiarie97%
    EX21:c828e5b5b9e5EX21:c828e5b5b9e5Subsidiarie97%
    EX21:ca66edb80229EX21:ca66edb80229Subsidiarie97%
    EX21:cba62f1bcd8dEX21:cba62f1bcd8dSubsidiarie97%
    EX21:cbe5f9357d20EX21:cbe5f9357d20Subsidiarie97%
    EX21:cd0bac11caaeEX21:cd0bac11caaeSubsidiarie97%
    EX21:cd4ce4a18482EX21:cd4ce4a18482Subsidiarie97%
    EX21:cd760335b0dcEX21:cd760335b0dcSubsidiarie97%
    EX21:d0eb164d5d8aEX21:d0eb164d5d8aSubsidiarie97%
    EX21:d140773f11eaEX21:d140773f11eaSubsidiarie97%
    EX21:d173da7edad7EX21:d173da7edad7Subsidiarie97%
    EX21:d2718716b76dEX21:d2718716b76dSubsidiarie97%
    EX21:d29f5e87c1e6EX21:d29f5e87c1e6Subsidiarie97%
    EX21:d2feca70a2cfEX21:d2feca70a2cfSubsidiarie97%
    EX21:d301580d57f1EX21:d301580d57f1Subsidiarie97%
    EX21:d637d04ece68EX21:d637d04ece68Subsidiarie97%
    EX21:da69cdbde619EX21:da69cdbde619Subsidiarie97%
    EX21:da8f7a78d5e3EX21:da8f7a78d5e3Subsidiarie97%
    EX21:db41196f8195EX21:db41196f8195Subsidiarie97%
    EX21:dc6a682abdb8EX21:dc6a682abdb8Subsidiarie97%
    EX21:dd2209d0b459EX21:dd2209d0b459Subsidiarie97%
    EX21:ddb492d98016EX21:ddb492d98016Subsidiarie97%
    EX21:e01cfda19972EX21:e01cfda19972Subsidiarie97%
    EX21:e4fc6b9acccfEX21:e4fc6b9acccfSubsidiarie97%
    EX21:e7291e497342EX21:e7291e497342Subsidiarie97%
    EX21:e72f5b682723EX21:e72f5b682723Subsidiarie97%
    EX21:eb5e1cd2d392EX21:eb5e1cd2d392Subsidiarie97%
    EX21:ebbc271cf330EX21:ebbc271cf330Subsidiarie97%
    EX21:eda04f4b9857EX21:eda04f4b9857Subsidiarie97%
    EX21:ef48ae634b74EX21:ef48ae634b74Subsidiarie97%
    EX21:f178013b644eEX21:f178013b644eSubsidiarie97%
    EX21:f2889aaa1d53EX21:f2889aaa1d53Subsidiarie97%
    EX21:f2bf071b143aEX21:f2bf071b143aSubsidiarie97%
    EX21:f3e0f87d16a8EX21:f3e0f87d16a8Subsidiarie97%
    EX21:f43bea1ade72EX21:f43bea1ade72Subsidiarie97%
    EX21:f4d99a0209caEX21:f4d99a0209caSubsidiarie97%
    EX21:f59e11b58871EX21:f59e11b58871Subsidiarie97%
    EX21:f7305eba64c9EX21:f7305eba64c9Subsidiarie97%
    EX21:f7be494b0d69EX21:f7be494b0d69Subsidiarie97%
    EX21:fab52c669ae0EX21:fab52c669ae0Subsidiarie97%
    EX21:fad522642a0aEX21:fad522642a0aSubsidiarie97%
    EX21:fb5a117ed1d5EX21:fb5a117ed1d5Subsidiarie97%
    EX21:fd10adaca29dEX21:fd10adaca29dSubsidiarie97%
    EX21:fd41f272f9ccEX21:fd41f272f9ccSubsidiarie97%
    EX21:fe8b58fce4f1EX21:fe8b58fce4f1Subsidiarie97%
    EX21:ff2edd356a66EX21:ff2edd356a66Subsidiarie97%

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    1,03
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    8
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-08-02 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate0,83
    Revenueno estimateno estimate3,5B USD
    Operating incomeno estimateno estimate257,1M USD
    Full-year consensus mean (period as reported by source) · consensus in USD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution8 analysts
    Strong buy3
    Buy4
    Hold1
    Sell0
    Strong sell0
    12-month price target$13,88 · Median $14,00
    Low $12,00High $16,00
    Operating income · consensus257,1M USD
    EPS surprise
    −162,3 %
    reported vs consensus · miss
    Revenue surprise
    −7,0 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$9,50
    Mean$13,19
    Median$13,50
    High$17,00
    Spot$10,24
    +28.8 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin2,8 %Above median
    Net Margin-2,2 %Above median
    ROE-4,7 %Below median
    Capex / Rev11,8 %Best in class
    D/E1,13Bottom quartile
    Cash Conv-8,50Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net disposed 89 451 sh1 exercises1 insiders
    • Prast Albert A.Chief Technology Officer · Employee Stock Option (right to buy) → Common StockDisposed 89 451 @ $4,38exercise · 2026-03-13

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Reference data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Ev To Revenue
      enterprise_value / revenue
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • AdaptHealth Corp. Market data — financials · 2026-08-02
    • reconciler_enqueue (reconciler) on AHCO.O · 2026-08-02
    • Adapthealth Corp Market data — analyst estimates · 2026-08-02
    • AHCO.O HA canonical relationships · 2026-08-02

    Ownership & reference

    Top holders

    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,02 %$33M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,02 %$82M
    • Arrowstreet Capital, Limited PartnershipInvestment Managers · as of 2026-03-310,01 %$10M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,01 %$12M
    • FMR LLCInstitutional Investor · as of 2026-03-310,01 %$96M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$19M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$25M
    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,00 %$5M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$136M
    • Invesco QQQ TrustFunds · as of 2026-03-310,00 %$20M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$32M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$15M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$13M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$51M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$117M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$3M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$8M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,00 %$2M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$7M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,00 %$3M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$10M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$1M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$0M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M

    Insider activity

    Net buying7 buys · 4 sellsnet $24,1M17 insiders · last 365d
    • Schuster III Russell E.Chief Commercial Officer · Common StockSold 11 275 @ $10,44$118K · 2026-07-01
    • Coppens Bradley JDirector · Common StockOther 18 999 · 2026-06-24
    • BELINFANTI GREGORYDirector · Common StockOther 18 999 · 2026-06-24
    • Connors Terence JDirector · Common StockOther 18 999 · 2026-06-24
    • Weaver Susan TDirector · Common StockOther 18 999 · 2026-06-24
    • Williams David Solomon IIIDirector · Common StockOther 18 999 · 2026-06-24
    • SAMET KENNETH ADirector · Common StockOther 18 999 · 2026-06-24
    • WOLF DALE BDirector · Common StockOther 18 999 · 2026-06-24
    • Lundberg Theodore B.Director · Common StockOther 18 999 · 2026-06-24
    • SAMET KENNETH ADirector · Common StockOther 6 070 @ $9,89$60K · 2026-06-24
    • Schuster III Russell E.Chief Commercial Officer · Common StockSold 11 275 @ $10,06$113K · 2026-06-01
    • McFadden Daniel EdwardChief Operating Officer · Common StockOther 20 134 · 2026-05-27
    • CASHIN RICHARD M JR10% owner · Common StockBought 447 100 @ $9,91$4,4M · 2026-03-20
    • CASHIN RICHARD M JR10% owner · Common StockBought 727 @ $9,94$7K · 2026-03-19
    • Prast Albert A.Chief Technology Officer · Common StockOther 89 451 @ $4,38$392K · 2026-03-13
    • Prast Albert A.Chief Technology Officer · Common StockOther 58 203 @ $10,33$601K · 2026-03-13
    • CASHIN RICHARD M JR10% owner · Common StockBought 689 336 @ $9,73$6,7M · 2026-03-12
    • CASHIN RICHARD M JR10% owner · Common StockBought 536 827 @ $9,73$5,2M · 2026-03-11
    • CASHIN RICHARD M JR10% owner · Common StockBought 820 528 @ $9,73$8,0M · 2026-03-10
    • Weaver Susan TDirector · Common StockOther 73 472 · 2026-03-05
    • WOLF DALE BDirector · Common StockBought 8 000 @ $8,96$72K · 2026-02-27
    • Rew Richard W. IICLO and General Counsel · Common StockBought 5 000 @ $8,91$45K · 2026-02-26
    • Barnhart Toby ScottChief Operating Officer · Common StockOther 68 330 · 2026-01-30
    • Rew Richard W. IICLO and General Counsel · Common StockOther 53 688 · 2026-01-30
    • Schuster III Russell E.Chief Commercial Officer · Common StockOther 48 807 · 2026-01-30

    Short positioning

    8.0Mshares short-0.6% vs prior
    7.42days to cover
    51.4%short of daily vol
    3.6Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    AHCO.OCanonical
    NASDAQ · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    AHCOEX21:013EX21:01bEX21:021EX21:070EX21:077EX21:0b1EX21:0b8EX21:0c9EX21:0f9EX21:108Health Care Pr
    This companySectorSubsidiaries

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-08-04 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-08-04EVENTUpcomingQ2 2026 earnings (expected) estimated date
    2026-07-01INSIDERSchuster III Russell E. sold 11.3k sh — Chief Commercial Officer ~$118k
    2026-06-24 00:00 UTCINSIDER10 insider transactions — 2026-06 · $173k gross
    2026-06-24INSIDERConnors Terence J transacted 19.0k sh — Director
    2026-06-24INSIDERBELINFANTI GREGORY transacted 19.0k sh — Director
    2026-06-24INSIDERCoppens Bradley J transacted 19.0k sh — Director
    2026-06-24INSIDERLundberg Theodore B. transacted 19.0k sh — Director
    2026-06-24INSIDERWilliams David Solomon III transacted 19.0k sh — Director
    2026-06-24INSIDERSAMET KENNETH A transacted 19.0k sh — Director
    2026-06-24INSIDERSAMET KENNETH A transacted 6.1k sh — Director ~$60k
    2026-06-24INSIDERWeaver Susan T transacted 19.0k sh — Director
    2026-06-24INSIDERWOLF DALE B transacted 19.0k sh — Director
    2026-06-01INSIDERSchuster III Russell E. sold 11.3k sh — Chief Commercial Officer ~$113k
    2026-05-27 00:00 UTCINSIDER1 insider transaction — 2026-05
    2026-05-27INSIDERMcFadden Daniel Edward transacted 20.1k sh — Chief Operating Officer
    2026-05-05FILING10-Q filing →
    2026-05-05FILING8-K filing →
    2026-04-28FILINGDEF 14A filing →
    2026-04-13FILING8-K filing →
    2026-03-20 00:00 UTCINSIDER9 insider transactions — 2026-03 · net buy $24.1M 1 derivative
    2026-03-20INSIDERCASHIN RICHARD M JR bought 447.1k sh — 10% owner ~$4.43M
    2026-03-19INSIDERCASHIN RICHARD M JR bought 727 sh — 10% owner ~$7k
    2026-03-13INSIDERPrast Albert A. transacted 89.5k sh — Chief Technology Officer ~$392k
    2026-03-13INSIDERPrast Albert A. transacted 58.2k sh — Chief Technology Officer ~$601k
    2026-03-13INSIDERPrast Albert A. disposed of 89.5k sh Employee Stock Option (right to buy) — Chief Technology Officer
    2026-03-12INSIDERCASHIN RICHARD M JR bought 689.3k sh — 10% owner ~$6.71M
    2026-03-11INSIDERCASHIN RICHARD M JR bought 536.8k sh — 10% owner ~$5.22M
    2026-03-10INSIDERCASHIN RICHARD M JR bought 820.5k sh — 10% owner ~$7.98M
    2026-03-05INSIDERWeaver Susan T transacted 73.5k sh — Director
    2026-02-27 00:00 UTCINSIDER2 insider transactions — 2026-02 · net buy $116k
    2026-02-27INSIDERWOLF DALE B bought 8.0k sh — Director ~$72k
    2026-02-26INSIDERRew Richard W. II bought 5.0k sh — CLO and General Counsel ~$45k
    2026-02-24FILING10-K filing →
    2026-02-24FILING8-K filing →
    2026-01-30 00:00 UTCINSIDER10 insider transactions — 2026-01
    2026-01-30INSIDERBarnhart Toby Scott transacted 68.3k sh — Chief Operating Officer
    2026-01-30INSIDERRew Richard W. II transacted 53.7k sh — CLO and General Counsel
    2026-01-30INSIDERSchuster III Russell E. transacted 48.8k sh — Chief Commercial Officer
    Showing the 40 most recent of 54 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Reference data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage